Tuesday, July 31, 2007

Serum protein alterations in dogs naturally infected with Toxo

Parasitol Res. 2007 Jul 22; [Epub ahead of print]

Serum protein alterations in dogs naturally infected with Toxoplasma gondii

Yarim GF, Nisbet C, Oncel T, Cenesiz S, Ciftci G

Department of Biochemistry, Faculty of Veterinary Medicine, University of Ondokuz Mayis, 55139, Kurupelit, Samsun, Turkey, gulyarim@omu.edu.tr.

We conducted this study to describe the serum electrophoretic pattern in dogs associated with the infection of Toxoplasma gondii (T. gondii). The serum protein pattern of 25 dogs with confirmed T. gondii infection and 15 clinically healthy dogs were evaluated using native polyacrylamide gel electrophoresis. Albumin, alpha-1 globulin, alpha-2 globulin, beta globulin, and gamma globulin bands were seen from the serum electrophoresis of infected and healthy dogs. Compared to the control group, significant decreases in the mean percentages of albumin (from 46.1 +/- 7.2 to 40.8 +/- 4.5%, P < 0.05), alpha-1 globulin (from 3.9 +/- 0.4 to 0.8 +/- 0.2%, P < 0.001), alpha-2 globulin (from 9.0 +/- 0.4 to 8.3 +/- 0.8%, P < 0.01), and beta globulin (from 18.4 +/- 1.2 to 12.1 +/- 0.6%, P < 0.001) in the infected group were determined. In contrast, gamma globulin fraction was significantly higher in infected dogs (38.1 +/- 4.6%) than in control dogs (22.7 +/- 7.2%; P < 0.001). Moreover, significant correlations were determined between the percentages of the albumin and gamma globulin fractions and liver enzyme tests including aspartate aminotransferase and alanine aminotransferase in infected dogs; however, no correlation was observed for the other protein fractions. In conclusion, marked alterations in serum protein pattern associated with strong modifications of serum protein concentrations are in accordance with the hepatic injury as affirmed by liver enzyme tests that were demonstrated in the canine toxoplasmosis. These findings showed that serum protein electrophoresis can be used in the diagnosis and prognosis of canine toxoplasmosis as a supplementary analysis in combination with serological, clinical, and laboratory findings of this disease.

PMID: 17659389 [PubMed - as supplied by publisher]

No comments: